IIH Practitioner Webinar Series

Idiopathic Intracranial Hypertension (IIH) is an underdiagnosed and undertreated disorder of elevated pressure within the brain without an identifiable cause. The IIH Practitioner Series is designed for neurologists, neurosurgeons, neuro-interventionalists, endovascular surgeons, interventionist radiologists, neuroradiologists, ophthalmologists, optometrists, and ENT specialists. Patients and caregivers are always welcome to attend.

Up Next

The River Stent™ and IIH

July 7, 2026

8:00 am Eastern

Join us on July 7 for our webinar featuring an expert discussion on the River Stent™ and its role in the treatment of Idiopathic Intracranial Hypertension (IIH).

This live webinar brings together two leading experts in neurointervention and cerebrovascular care to discuss the evolving treatment landscape for IIH, patient selection considerations, procedural insights, and real-world experience with venous sinus stenting.

The session will be moderated by Dr. Pierre Gobin and will feature Dr. Adnan Siddiqui, a renowned neurosurgeon and leader in neurovascular innovation. Attendees will gain practical perspectives on the use of the River Stent and have the opportunity to hear directly from experienced practitioners in the field.

Dr. Adnan Siddiqui

UB Distinguished Professor and Vice Chairman, Department of Neurosurgery SUNY Buffalo Jacobs School of Medicine and Biomedical Sciences

Dr. Adnan H. Siddiqui is a University at Buffalo Distinguished Professor and Vice Chairman of Neurosurgery at the Jacobs School of Medicine and Biomedical Sciences, internationally recognized for his expertise in cerebrovascular and endovascular neurosurgery. With specialized training in interventional neuroradiology, cerebrovascular surgery, and neurocritical care, he has extensive experience treating complex neurovascular conditions, including stroke, aneurysms, arteriovenous malformations, and venous disorders.

Dr. Siddiqui has authored more than 600 peer-reviewed publications, contributed over 50 book chapters, and delivered more than 400 presentations at leading cerebrovascular conferences worldwide. He has designed and led numerous national and international clinical trials and currently serves as principal investigator for multiple multicenter studies advancing neurovascular care and medical device innovation.

Dr. Siddiqui is Chief Executive Officer and Chief Medical Officer of the Jacobs Institute, where he works with physicians, researchers, engineers, and industry partners to accelerate the development of new technologies for vascular disease. He also directs the Canon Stroke and Vascular Research Center and the Neurosurgical Stroke Service at Buffalo’s Gates Vascular Institute, one of the busiest comprehensive stroke centers in the United States. His contributions to research, education, and innovation have earned numerous honors, including the SUNY Chancellor’s Award for Excellence in Scholarship and Creative Activities and designation as a University at Buffalo Distinguished Professor.

Dr. Pierre Gobin

Director of Interventional Neuroradiology, New York-Presbyterian Hospital/Weill Cornell Medical Center

Y. Pierre Gobin, MD, is an internationally recognized expert in the field of interventional neuroradiology, with 20 years of experience in the treatment of vascular diseases of the brain, head and neck, and spine. A pioneer in endovascular treatment of cerebral aneurysms, Dr. Gobin has also developed and established minimally invasive surgical approaches to treat acute strokes.

Dr. Gobin completed his medical degree, internship and radiology residency at the University of Paris, France in 1988. He trained in interventional neuroradiology at Hospital Lariboisiere in Paris, where he performed the first GDC coil embolization in France, in a patient with a cerebral aneurysm.

Dr. Gobin was recruited by the Division of Interventional Neuroradiology of the University of California at Los Angeles in 1992, and was a member of the faculty there for nine years. While at UCLA, he participated in further clinical evaluation of GDC technology, which was invented at that institution.

In recent years, he conceived the Concentric Retriever, an endovascular device for cerebral embolectomy to treat acute stroke. He is also the endovascular member of the team that developed intra arterial chemotherapy for the treatment of retinoblastoma.

Since 2001, Dr. Gobin is professor of radiology in neurosurgery and neurology at the Weill Cornell Medical College and director of Interventional Neuroradiology at the NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

Dr. Gobin is the author of more than 100 articles and reviews pertaining to interventional neuroradiology.